title: Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept.
authors.affiliation: Allergy Department, Hospital Universitario La Paz, Madrid, Spain. natalycf@gmail.com
authors.forename: N
authors.initials: N
authors.lastname: Cancelliere
authors.forename: P
authors.initials: P
authors.lastname: Barranco
authors.forename: C
authors.initials: C
authors.lastname: Vidaurrázaga
authors.forename: D-M
authors.initials: DM
authors.lastname: Benito
authors.forename: S
authors.initials: S
authors.lastname: Quirce
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000209:etiology*; D004802:Eosinophilia / Q000139:chemically induced* / Q000188:drug therapy; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use; D000069285:Infliximab; D011536:Prurigo / Q000139:chemically induced* / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068800:Etanercept